Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIM homeobox protein 5 (Lhx5) is a transcription factor characterized by containing two LIM domains and a central homeodomain, allowing it to bind DNA and regulate the expression of downstream genes crucial for development[3][4]. It is most highly expressed in early stages of brain development, particularly in the hypothalamic mamillary body, hippocampus, and hindbrain. Loss of Lhx5 results in severe neurodevelopmental defects in mice, including lack of mamillary body formation and deficits in neuron migration, memory, and motor function[3]. While other LIM homeobox family members are associated with cancer progression and biomarker potential, Lhx5 itself has not yet been directly implicated as a therapeutic target or marker in humans[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIM homeobox protein 5 (Lhx5).